And here comes the equity dilution!Very predictable. Up to $100M approved with Canacord leading the charge. They have chosen an ATM model which basically means any spike in stock and they will sell these shares into market diluting the heck out of this thing even further and really limiting any massive surge. Too bad for current shareholders. Not a fan of this at all as there is no specific clarity or price for the equity offerings will be at market on any days mgmt chooses to sell. I think this limits current shareholders updside with little transparency.